MMH
IMMU

Menora Mivtachim Holdings’s Immunomedics Inc IMMU Stock Holding History

Menora Mivtachim Holdings’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,434,900
Closed -$19M – 65
2019
Q3 		$19M Buy
1,434,900
+925,000
+181% +$13.6M 0.46% 51
2019
Q2 		$7.07M Hold
509,900
– – 0.19% 53
2019
Q1 		$9.79M Hold
509,900
– – 0.26% 61
2018
Q4 		$7.28M Hold
509,900
– – 0.21% 71
2018
Q3 		$10.6M Hold
509,900
– – 0.29% 76
2018
Q2 		$12.1M Buy
+509,900
New +$10.2M 0.34% 80

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Menora Mivtachim Holdings's IMMU Position: Q4 2019 in Review

Menora Mivtachim Holdings sold out of Immunomedics Inc (IMMU) in Q4 2019, closing a stake of 1,434,900 shares — an estimated $19M sold.

Menora Mivtachim Holdings first reported a position in IMMU in Q2 2018 and held it in 6 quarters. The position peaked at $19M in Q3 2019. 245 funds tracked by Wall St. Rank hold IMMU as of Q4 2019.

  • Menora Mivtachim Holdings reported no remaining Immunomedics Inc position as of Q4 2019 after selling out during the quarter.
  • Menora Mivtachim Holdings sold 1,434,900 Immunomedics Inc shares in Q4 2019, an estimated $19M.
  • Menora Mivtachim Holdings first reported a position in Immunomedics Inc in Q2 2018 and held it in 6 quarters.
  • Menora Mivtachim Holdings's Immunomedics Inc position peaked at $19M in Q3 2019.
  • 245 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2019.

Based on Menora Mivtachim Holdings's 13F filing for Q4 2019, filed 30 Jan 2020.